What is CBD? The 'miracle' cannabis compound that doesn't
What is CBD? The 'miracle' cannabis compound that doesn't get you high
Cannabis
High time: a grownup's guide to the cannabis revolution
The cannabis-derived chemical is non-psychoactive, and – while federally illegal – has been hailed as a cure for disease
Alex Halperin
@alexhalperin
Mon 28 May 2018 07.00 EDT
‘Many users believe CBD helps them relax ... and some believe regular doses help stave off Alzheimer’s and heart disease.’
‘Many users believe CBD helps them relax ... and some believe regular doses help stave off Alzheimer’s and heart disease.’ Illustration: George Wylesol
In early May, a federal court ruled that cannabidiol (CBD), a chemical produced by the cannabis plant, is federally illegal, in the same category as LSD and heroin, which the government considers to be dangerous and devoid of medical value.
The ruling was contrary to existing evidence, which suggests the chemical is safe and could have multiple important uses as medicine. Many cannabis advocates consider it a miracle medicine, capable of relieving conditions as disparate as depression, arthritis and diabetes.
The perception of its widespread medical benefits have made the chemical a rallying cry for legalization advocates.
The first thing to know about CBD is that it is not psychoactive; it doesn’t get people high. The primary psychoactive ingredient in marijuana is tetrahydrocannabinol (THC). But THC is only one of the scores of chemicals – known as cannabinoids – produced by the cannabis plant.
So far, CBD is the most promising compound from both a marketing and a medical perspective. Many users believe it helps them relax, despite it not being psychoactive, and some believe regular doses help stave off Alzheimer’s and heart disease.
Expots: medical marijuana draws parents to US for their children's treatments
Read more
While studies have shown CBD to have anti-inflammatory, anti-pain and anti-psychotic properties, it has seen only minimal testing in human clinical trials, where scientists determine what a drug does, how much patients should take, its side effects and so on.
Despite the government ruling, CBD is widely available over the counter in dispensaries in states where marijuana is legal.
CBD first came to public attention in a 2013 CNN documentary called Weed. The piece, reported by Dr Sanjay Gupta, featured a little girl in Colorado named Charlotte, who had a rare life-threatening form of epilepsy called Dravet syndrome.
At age five, Charlotte suffered 300 grand mal seizures a week, and was constantly on the brink of a medical emergency. Through online research, Charlotte’s desperate parents heard of treating Dravet with CBD. It was controversial to pursue medical marijuana for such a young patient, but when they gave Charlotte oil extracted from high-CBD cannabis, her seizures stopped almost completely. In honor of her progress, high-CBD cannabis is sometimes known as Charlotte’s Web.
CBD has been sought for its healing properties.
Facebook
Twitter
Pinterest
CBD has been sought for its healing properties. Illustration: George Wylesol
After Charlotte’s story got out, hundreds of families relocated to Colorado where they could procure CBD for their children, though not all experienced such life-changing results. Instead of moving, other families obtained CBD oil through the illegal distribution networks.
Advertisement
In late June, the US Food and Drug Administration could approve the Epidiolex, a pharmaceuticalized form of CBD for several severe pediatric seizure disorders. According to data recently published in the New England Journal of Medicine, the drug can reduce seizures by more than 40%. If Epidiolex wins approval it would be the first time the agency approves a drug derived from the marijuana plant. (The FDA has approved synthetic THC to treat chemotherapy-related nausea.)
Epidiolex was developed by the London-based GW Pharmaceuticals, which grows cannabis on tightly controlled farms in the UK. It embarked on the Epidiolex project in 2013, as anecdotes of CBD’s value as an epilepsy drug began emerging from the US.
While parents treating their children with CBD had to proceed based on trial and error, like a folk medicine, they also had to wonder whether dispensary purchased CBD was professionally manufactured and contained what the package said it did. GW brought a scientific understanding and pharmaceutical grade manufacturing to this promising compound.
Fortunately, like THC, CBD appears to be well tolerated; as far as I can tell, there are no recorded incidents of fatal CBD overdoses.
Since Weed first aired, GW’s stock has climbed 1,500%.
Should I grow my own weed at home? Here's what you need to know
Read more
GW’s first drug Sativex, which contains both CBD and THC, is available as a treatment for MS-related spasticity in Canada, Australia, and much of Europe and Latin America. The company is also studying cannabinoid-based drugs as a treatment for autism spectrum disorders, an aggressive brain tumor called glioblastoma, and schizophrenia.
Other industries, not subject to the strict regulations governing pharmaceuticals are eager to develop their own CBD products, everything from joints and vape pens to skin creams and edibles which may or may not have valid medical use.
In Los Angeles, it’s among the latest wellness fads. It can be found in cocktails, and an upscale juice shop will even add a few drops of CBD infused olive oil to a beverage for $3.50.
High time is the Guardian’s column about how cannabis legalization is changing modern life. Alex Halperin welcomes your thoughts, questions and concerns and will protect your anonymity. Get in touch:high.time@theguardian.com
7
Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...
Continue Reading
IFA 2026: A New Frontier for Desktop Printing You've seen your fair share of printers over the years, but when a company like Morpho steps onto the scene with a gadget that echoes innovation, it makes you perk up those market-ears. We're talking the big unveil of their desktop UV printer at the IFA 2026 in Berlin. Morpho's contraption isn't just spewing out ink; it's...
Continue Reading
Ever seen a whole nation's hygiene industry getting a deep dive from not just one, but three major standards bodies? That's what just went down in Senegal. Softcare opened its doors wide to folks from the Senegalese Association for Standardization (ASN), the International Organization for Standardization (ISO), and the Swedish Institute for Standards (SIS). This was no...
Continue Reading
A Fresh Breeze in Climate Control Here's something that'll shake up your household. Midea just announced their latest gizmo, called VitaBreeze, and they’re not messing around. They introduced it at IFA 2026, promising it's not just for cooling off in the summer or heating in the winter. Oh no, my friends, they've packed this unit with enough cutting-edge tech that...
Continue Reading
Something's got folks eyeing Whidbey Island like a gambler with a hot tip—and it ain't just the thrill of a vacation spot. Anyone with half a brain knows real estate moves in waves, and right now, Whidbey Island's caught some serious momentum. You can't ignore the pull of natural beauty, access to city life, and that laid-back vibe that seems to whisper "slow down and...
Continue Reading
While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...
Continue Reading
Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....
Continue Reading
The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...
Continue Reading
Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...
Continue Reading
Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...
Continue Reading
Top 5 Most Recently Viewed Articles
Reports emerged highlighting a serious concern with Boeing 737 airplanes that could spell trouble for more than 40 foreign operators. The U.S. National Transportation Safety Board (NTSB) dropped a bombshell, indicating these aircraft might be flying with rudder components posing significant safety risks. NTSB Urgency: Safety Recommendations Triggered The NTSB’s warning...
Continue Reading
Overview of Firefly Aerospace Class Action Lawsuit Recent developments have emerged regarding the legal challenges faced by Firefly Aerospace Inc. This space and defense technology company is now entangled in a class action lawsuit filed by its investors who have reported considerable financial losses. Those who purchased securities during a specific timeframe,...
Continue Reading
Recent Transactions by TORM plc’s Leadership On a notable date, TORM plc (NASDAQ: TRMD), a leader in the transportation of refined oil products, was informed of significant transactions involving its securities. This communication highlights the ongoing commitment of the organization to maintain transparency in its operations, particularly concerning the trading...
Continue Reading
A Game-Changing Approach to Social Media Monetization Mark Cuban, the billionaire entrepreneur, has recently introduced a revolutionary patent designed to change the way social media users earn money from their content. This patent paves the way for both social media platforms and their users to take advantage of advertising opportunities linked to their profiles. Details...
Continue Reading
Legal Expertise Meets Market Ambition When you're looking for a law firm that gets the job done, Lucosky Brookman is the one to call. Today's big news is that they've guided Optimi Health Corp. through the bureaucracy and snags of Nasdaq's listing approval process. This is no small feat given how extensive and rigorous Nasdaq scrutinizations can be—the folks over there...
Continue Reading
